Breen Michael Martin
CIK 0001863633
Executive Chairman/Interim CEODirector
Filings
5
Latest Sep 8, 2025
Issuers covered
2
Showing
5 of 5
Page 1
Track record
1 of 2 open-market trades scored (50% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -41.5% | -41.5% | -41.5% | -41.5% |
| 90 days | 1 | 0% | -46.2% | -46.2% | -46.2% | -46.2% |
| 180 days | 1 | 0% | -53.8% | -53.8% | -53.8% | -53.8% |
| 365 days | 1 | 0% | -74.4% | -74.4% | -74.4% | -74.4% |
Issuers
Companies where Breen Michael Martin has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| GTBP | Gt Biopharma, Inc. | 4 | Sep 8, 2025 |
| PROP | Prairie Operating Co. | 1 | May 5, 2023 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|